Pubblicazioni

Randomized phase II trial of weekly paclitaxel vs. cediranib-olaparib (continuous or intermittent schedule) in platinum-resistant high-grade epithelial ovarian cancer

2022 - GYNECOLOGIC ONCOLOGY

Colombo, N.; Tomao, F.; Benedetti Panici, P.; Nicoletto, M. O.; Tognon, G.; Bologna, A.; Lissoni, A. A.; DeCensi, A.; Lapresa, M.; Mancari, R.; Palaia, I.; Tasca, G.; Tettamanzi, F.; Alvisi, M. F.; Rulli, E.; Poli, D.; Carlucci, L.; Torri, V.; Fossati, R.; Biagioli, E.

Multi-Center Randomized Phase II Clinical Trial on Remote Ischemic Conditioning in Acute Ischemic Stroke Within 9 Hours of Onset in Patients Ineligible to Recanalization Therapies (TRICS-9): Study Design and Protocol

2021 - FRONTIERS IN NEUROLOGY

Diamanti, Susanna; Beretta, Simone; Tettamanti, Mauro; Sacco, Simona; Sette, Giuliano; Ornello, Raffaele; Tiseo, Cindy; Caponnetto, Valeria; Beccia, Mario; Alivernini, Diletta; Costanzo, Rocco; Ferrarese, Carlo

Non-pegylated liposomal doxorubicin plus ifosfamide in metastatic soft tissue sarcoma: results from a phase-II trial

2015 - ANTICANCER RESEARCH

DE SANCTIS, RITA; Bertuzzi, Alexia; Basso, Umberto; Comandone, Alessandro; Marchetti, Silvia; Marrari, Andrea; Colombo, Piergiuseppe; Lutman, Romano Fabio; Giordano, Laura; Santoro, Armando